Ling Li from Baltimore, MD

Professional Records

Lawyers & Attorneys

Ling Li - Lawyer

View page

Address:

State Grid International Development Limited
(108) 228-8878 (Office)

Licenses:

New York - Currently registered 2004

Education:

Beijing University
Stanford

Ling Li - Lawyer

View page

Licenses:

New York - Currently registered 2012

Education:

Rutgers School of Law - Newark

Ling Li - Lawyer

View page

Address:

King & Wood Mallesons

Licenses:

New York - Currently registered 2008

Education:

Tulane University Law School

Ling Li - Lawyer

View page

ISLN:

1000542440

Admitted:

2003

Medicine Doctors

Ling Li

View page

Specialties:

Neurology

Work:

Mercy ClinicMercy Clinic Neurology
2115 S Fremont Ave STE 3000, Springfield, MO 65804
(417) 820-9123 (phone), (417) 820-3935 (fax)

Education:

Medical School
Shanghai Med Univ, Shanghai First Med Univ, Shanghai, China
Graduated: 1991

Procedures:

Lumbar Puncture
Neurological Testing
Sleep and EEG Testing

Conditions:

Peripheral Nerve Disorders
Alzheimer's Disease
Bell's Palsy
Carpel Tunnel Syndrome
Dementia

Languages:

English
Spanish

Description:

Dr. Li graduated from the Shanghai Med Univ, Shanghai First Med Univ, Shanghai, China in 1991. She works in Springfield, MO and specializes in Neurology. Dr. Li is affiliated with Mercy Hospital Springfield.

Ling Li, Baltimore MD

View page

Specialties:

Forensic Pathology

Address:

Forensic Medical Examiners
900 W Baltimore St, Baltimore, MD 21223
(410) 333-3250 (Phone)

Languages:

English

Ling Li

View page

Specialties:

Anatomic Pathology & Clinical Pathology

Work:

Forensic Medical Examiners
900 W Baltimore St, Baltimore, MD 21223
(410) 333-3250 (phone), (410) 333-3063 (fax)

Education:

Medical School
Tongji Med Univ, Wuhan City, Hubei, China
Graduated: 1982

Languages:

English

Description:

Dr. Li graduated from the Tongji Med Univ, Wuhan City, Hubei, China in 1982. She works in Baltimore, MD and specializes in Anatomic Pathology & Clinical Pathology. Dr. Li is affiliated with University Of Maryland Medical Center.

Ling Li

View page

Specialties:

Internal Medicine

Work:

Institute Of Living
200 Retreat Ave, Hartford, CT 06106
(860) 545-7224 (phone), (860) 545-7268 (fax)

Languages:

English

Description:

Ms. Li works in Hartford, CT and specializes in Internal Medicine. Ms. Li is affiliated with Institute Of Living-Hartford Hospital.

Ling Li

View page

Specialties:

Legal Medicine
Anatomic Pathology
Forensic Pathology

Ling Li

View page

Specialties:

Legal Medicine
Pathology
Anatomic Pathology
Forensic Pathology
Anatomic Pathology & Clinical Pathology
Urology

Education:

Tongji Medical University (1982)

Ling Li, Baltimore MD

View page

Specialties:

Forensic Pathologist

Address:

111 Penn St, Baltimore, MD 21201

License Records

Ling Li

License #:

48761 - Active

Issued Date:

Jul 20, 2010

Expiration Date:

Jun 30, 2018

Type:

Civil Engineer

Organization:

OCEAN STEEL & CONSTRUCTION LTD

Business Records

Name / Title

Company / Classification

Phones & Addresses

Ling Li
Director

Houston United Power Technical Co., Ltd

Ling Li

TIANMEI BEST LIFE LLC

Ling Li
Pathologist

Maryland Department of Health & Mental Hygiene
Administrative Public Health Programs

111 Penn St, Baltimore, MD 21201
900 W Baltimore St, Baltimore, MD 21223
(410) 333-3250

Ling Li
President

Bay Gallery
Museum/Art Gallery

158 Main St, Annapolis, MD 21401

Ling Li
President

New China 88, Inc
Ret Misc Homefurnishings

4217 NW 16 Blvd, Gainesville, FL 32605
6106 Edmondson Ave, Baltimore, MD 21228

Publications

Us Patents

Compositions And Methods Of Treating Liver Cancers

View page

US Patent:

20220226342, Jul 21, 2022

Filed:

Jun 29, 2020

Appl. No.:

17/623060

Inventors:

- Baltimore MD, US
Ling Li - Baltimore MD, US

International Classification:

A61K 31/55
A61P 35/00

Abstract:

Described herein are methods for treating liver tumors and cancer in a subject comprising the steps of administering a suppressor of protein translation to a subject in need thereof. Examples of liver cancer include hepatocellular carcinoma (HCC), cholangiocarcinoma, or a combination thereof. Examples of a suppressor of protein translation includes omacetaxine mepusuccinate, and the methods include combinations with other chemotherapeutic agents.

Bortezomib-Loaded Nanoparticles

View page

US Patent:

20230074885, Mar 9, 2023

Filed:

Feb 5, 2021

Appl. No.:

17/797053

Inventors:

- Baltimore MD, US
Hai-Quan Mao - Baltimore MD, US
Ling Li - Baltimore MD, US
Yang Zhou - Baltimore MD, US
Zhiyu He - Baltimore MD, US
Kuntao Chen - Philadelphia PA, US

International Classification:

A61K 47/64
A61K 9/51
A61K 47/54
A61K 45/06
A61P 35/00

Abstract:

The presently disclosed subject matter provides nanoparticles comprising bortezomib encapsulated in a non-water-soluble polymer matrix in a form of a bortezomib-tannic acid complex; methods for preparing the nanoparticle; and use of the nanoparticles for treating liver cancer.

Mini-Cancers Utilization For Personalized Cancer Drug Regimens

View page

US Patent:

20210333265, Oct 28, 2021

Filed:

Feb 1, 2018

Appl. No.:

16/479652

Inventors:

- Baltimore MD, US
Ling Li - Baltimore MD, US

International Classification:

G01N 33/50
G01N 33/574

Abstract:

The present invention includes methods for identifying chemotherapy treatments specifically suited for each cancer patient using mini-cancers to develop personalized cancer drug regimes.

Organ Directed Gene Delivery

View page

US Patent:

20200345867, Nov 5, 2020

Filed:

Apr 30, 2020

Appl. No.:

16/864130

Inventors:

- Baltimore MD, US
Vivek Kumbhari - Baltimore MD, US
Ling Li - Baltimore MD, US

International Classification:

A61K 48/00
C12N 15/63
A61P 1/18
A61P 1/16

Abstract:

Intrabiliary hydrodynamic injection of nucleic acid for in vivo gene therapy for treatment of liver or pancreas disease and other disorders.

Extracellular Vesicles For Agent Delivery

View page

US Patent:

20200197535, Jun 25, 2020

Filed:

Nov 11, 2019

Appl. No.:

16/679445

Inventors:

- BALTIMORE MD, US
LING LI - BALTIMORE MD, US
STEPHEN J. GOULD - BALTIMORE MD, US

Assignee:

THE JOHNS HOPKINS UNIVERSITY - BALTIMORE MD

International Classification:

A61K 48/00
C12P 1/00
A61K 31/7105
A61K 47/69
G01N 33/574
A61P 25/00
A61K 35/33
A61K 35/13
C12N 15/113
A61K 33/243
C12P 21/00
A61K 9/107
A61K 31/685
A61K 31/704
A61K 33/24
A61K 45/06
C12P 19/34

Abstract:

The present invention relates to the field of extracellular vesicles. More specifically, the present invention provides methods and compositions for using extracellular vesicles as a vector for nucleic acid treatment in vivo of various diseases. In a specific embodiment, the present invention provides an extracellular vesicle isolated from a cell comprising one or more microRNAs (miRNAs) that have been loaded ex vivo into the vesicle so that the miRNAs are present in a higher concentration than when measured in the same extracellular vesicle isolated directly from the cell. In another embodiment, the present invention provides a method for treating cholangiocarcinoma in a subject comprising the step of administering to the subject a plurality of exosomes comprising miR-

Mini-Cancers Utilization For Personalized Cancer Drug Regimens

View page

US Patent:

20200018743, Jan 16, 2020

Filed:

Sep 26, 2019

Appl. No.:

16/583738

Inventors:

- Baltimore MD, US
Ling Li - Baltimore MD, US

International Classification:

G01N 33/50
G16H 50/30
G16H 50/50
G16H 50/20
G16H 20/10
G16B 40/10

Abstract:

The present invention includes methods for identifying chemotherapy treatments specifically suited for each cancer patient using mini-cancers to develop personalized cancer drug regimes.